Helmholtz Zentrum München receives EU funding for Lung Disease Project

In an attempt  to enhance the treatment regimen for infectious diseases worldwide, Helmholtz Zentrum München has received a funding for 3.9 million euros from the European Commission. The project is called "Cell2Cell Heterogeneity" and it will officially start from November 2019. This project will be funded for 4 years. This is a large collaborative project involving research institutions and Biotech companies.

For further information, please read the press release of Helmholtz Zentrum Munich

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.